Recent investigations have unveiled a unique subset of tumors within this category, characterized by their IDH wildtype status, oligodendroglioma-like morphology, and BRAF p.V600E mutation [73, 75–77]. The gene discussed is IDH2; the disease is oligodendroglioma.